November 6, 2015 -- The Medicare Payment Advisory Commission discussed options to reduce Medicare Part B drug payments to hospitals participating in the 340B program during its November public meeting, held yesterday. MedPAC previously raised this issue in its June 2015 report to Congress but made no recommendations. … [Read more...]
OIG Plans to Issue Two Studies on 340B in FY 2016
Topics are Part B reimbursement and Medicaid managed care duplicate discountsNovember 5, 2015—The Department of Health and Human Services Inspector General plans to issue a pair of reports about the 340B program this fiscal year. … [Read more...]
OIG Clarifies Policy on Hospitals Waiving Patients’ Drug Charges
No sanctions for discounts or waivers on self-administered outpatient drugs Part B doesn't coverNovember 5, 2015—Hospitals needn't worry about getting slapped with federal anti-kickback sanctions if they waive all or part of what patients owe for self-administered drugs provided during outpatient stays and that Medicare Part B doesn't cover, the Department of Health and Human Services says. … [Read more...]
Senate, House, and HHS Are All Talking About Rising Drug Prices
Activity comes a week after Congress addressed generic drug prices in budget legislationNovember 4, 2015—The rising cost of prescription drugs is reaching critical mass at the federal level, with a Senate committee today announcing a bipartisan investigation, top House Democrats today announcing a task force, and the Department of Health and Human Services yesterday announcing a daylong summit later this month. … [Read more...]
Hospitals Say 340B Mega-Guidance Would Undermine Patient Care
HRSA received more than 800 comments by Oct. 27 deadlineOctober 28, 2015—Hospitals and vulnerable patients will suffer if federal health officials finalize proposed 340B drug discount program guidelines in their present form, three major hospital associations say. … [Read more...]
Senators Ask FTC to Investigate Makers of IV Saline Solution
Manufacturers' actions indicate possible collusion to boost profitsOctober 27, 2015—A bipartisan group of U.S. Senators has asked the Federal Trade Commission to investigate whether makers of generic intravenous saline solution have colluded to exploit a shortage in order to boost profits. … [Read more...]
AIDS Healthcare Foundation Launches Pro-340B TV Ad Campaign
Spots Will Run for Six Weeks on Fox and CNNOctober 22, 2015 – The AIDS Healthcare Foundation today announced a new television ad campaign aimed at shaming the drug industry and bolstering support for the 340B program in Congress. … [Read more...]